Clinical Trials in Pittsburgh

Showing 2481-2500 of 18,076 trials

MR Imaging of Perinatal Brain Injury

NCT02008045

The purpose of this study is to collect and compare information from cranial ultrasounds, magnetic resonance imaging scans, neurological exam and neuropsychological assessments of children. The investigators hope that the information collected in this study will help with early screening, diagnosis and treatment of brain injury in newborns as well as identify a connection between MR imaging (MRI-magnetic resonance imaging, MRS-magnetic resonance spectroscopy) and neurodevelopmental outcome.

Perinatal White Matter Brain Injury

University of Pittsburgh557 participantsStarted Jul 2009

Pittsburgh, Pennsylvania, United States

RECRUITINGPhase 1< 1 mile

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

NCT05614739

The main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-435 by itself or when it is combined with other standard medicines that treat cancer. LOXO-435 may be used to treat cancer of the cells that line the urinary system and other solid tumor cancers that have a change in a particular gene (known as the FGFR3 gene). Participation could last up to 30 months (2.5 years) and possibly longer if the disease does not get worse.

Urinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms

Eli Lilly and Company535 participantsStarted Jan 2023

Tucson, Arizona, United States • Duarte, California, United States • Los Angeles, California, United States +81 more locations

MR Imaging of Perinatal Brain Injury

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

Find Trials by Condition in Pittsburgh

A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

Liver Cirrhosis Network Cohort Study

A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)

Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma

ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas

A Study in Patients With Mixed Dyslipidemia

Data Collection for the Validation of an Artificial Intelligence Software to Support Musculoskeletal Ultrasound Examination

Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV

Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery

Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma